Pheochromocytoma (Pheo) is the second most common adrenal tumour in dogs. It is of neuroectodermal origin arising from chromaffin cells of the sympathoadrenal system. Clinical signs result from excretion of excessive amounts of catecholamines and rarely from the direct presence and space occupying nature of the tumour. Pheo is identified most commonly in older dogs (> 7 years). There does not seem to be a sex or breed predilection. Symptoms are subtle, episodic and often complicated by concurrent disease.
The most common clinical signs are generalized weakness and episodic collapse. Further symptoms include intermittent agitation, pacing, excessive panting, pu/pd. Systemic hypertension may occur leading to retinal detachment or retinal haemorrhage or hemorrhage into the retroperitoneal space, the abdominal cavity or the CNS. Vomiting, diarrhea, inappetence, weight loss, tender abdomen and cardiac arrhythmias may also be seen.
Signs related to a space-occupying process are a palpable mass, enlarged abdomen, ascites and rear limb edema. Collapse and death from a sudden, massive and sustained release of the catecholamines and massive haemorrhage due to sudden increase in blood pressure or rupture of the tumour is possible. Many of the clinical signs caused by pheo are unspecific and vague and may be associated with a variety of more frequent diseases. There are no consistent abnormalities on haematology, serum biochemistry and urinalysis which would raise the suspicion of pheo. Up till recently the majority of cases were therefore only diagnosed at necropsy and were not suspected antemortem. However, due to the fact that abdominal ultrasonography including adrenal imaging is increasingly used as part of a diagnostic work-up, the situation has started to improve. Often, pheo is only considered after an adrenal mass is identified on abdominal ultrasonography. Although normal sized adrenal glands do not rule out pheo, there seems to be a relationship between tumour size and severity of clinical signs. In most dogs with obvious clinical signs the tumour is easily detectable. Different to the situation in human medicine the majority of pheos in dogs are malignant. Ultrasonography can provide information regarding local invasion to surrounding tissue and vessels, tumour thrombi and metastasis to other abdominal organs. In more than 50% of dogs with pheo tumour thrombi and/or metastasis are present at the time of diagnosis.